Activation of K_ATP channels increases anticancer drug delivery to brain tumors and survival

Keyphrases

• KATP Channel 100%
• Brain Tumor 100%
• Brain Drug Delivery 100%
• Anticancer Drug Delivery 100%
• Temozolomide 75%
• Herceptin 62%
• Tumor Barriers 37%
• Human Epidermal Growth Factor Receptor 2 (HER2) 25%
• Brain Tumor Patients 25%
• Patient Survival 25%
• Antitumor Effect 12%
• Antineoplastic Agents 12%
• Anticancer Drugs 12%
• Glioma 12%
• Anticancer Agents 12%
• Combination Treatment 12%
• Antibody Delivery 12%
• Nude Mice 12%
• Glioma Model 12%
• Trastuzumab 12%
• Agent Delivery 12%
• ATP-sensitive Potassium Channel 12%
• Carboplatin 12%
• Fluorescently Labeled 12%
• Glioblastoma multiforme 12%
• Blood-brain Tumor Barrier 12%
• Her2neu 12%
• Vascular Endothelial 12%
• Minoxidil Sulphate 12%
• Antitumor Activity 12%
• Co-infusion 12%
• Glioblastoma multiforme Cells 12%
• Potassium Channel 12%
• Selective Drug Delivery 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Anticarcinogen 100%
• Adenosine Triphosphate Sensitive Potassium Channel 100%
• Intracranial Tumor 100%
• Temozolomide 54%
• Trastuzumab 54%
• Neoplasm 18%
• Glioblastoma 18%
• Carbon 14 9%
• Nude Mouse 9%
• Carboplatin 9%
• Minoxidil Sulfate 9%
• Potassium Channel 9%

Neuroscience

• Adenosine Triphosphate Sensitive Potassium Channel 100%
• Anticarcinogen 100%
• Intracranial Tumor 100%
• Trastuzumab 54%
• Temozolomide 54%
• Agonist 18%
• Glioblastoma Multiforme 18%
• Potassium Channel 9%
• Carboplatin 9%
• Minoxidil Sulfate 9%